Patents by Inventor Molly HESS

Molly HESS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS TO MAKE GLP1 RA AND INTERMEDIATES THEREFOR
    Publication number: 20260209224
    Abstract: The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.
    Type: Application
    Filed: December 18, 2023
    Publication date: July 23, 2026
    Inventors: Ayman D. ALLIAN, Kenneth Derek BERGLUND, Kevin Paul COLE, Ashlee Jeanette DAVIS, Molly HESS, Adrianna JEMISON, Mark Steven KERR, Audrey Grace MACK, Xavier A. ORTIZ-MEDINA, David Michael REMICK, Derek Robert STARKEY, Radhe Krishan VAID, Qiang YANG, Fumiki KAWAGISHI, Takashi EMURA, Satoshi TSUCHIYA, Manabu WADAMOTO, Minoru YAMAWAKI, James Craig RUBLE
  • Process to make GLP1 RA and intermediates therefor
    Patent number: 12365682
    Abstract: The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl ]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.
    Type: Grant
    Filed: September 3, 2024
    Date of Patent: July 22, 2025
    Assignees: ELI LILLY AND COMPANY, CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Ayman D. Allian, Kenneth Derek Berglund, Kevin Paul Cole, Ashlee Jeanette Davis, Molly Hess, Adriana Jemison, Mark Steven Kerr, Audrey Grace Mack, Xavier A. Ortiz-Medina, David Michael Remick, Derek Robert Starkey, Radhe Krishan Vaid, Qiang Yang, Fumiki Kawagishi, Takashi Emura, Satoshi Tsuchiya, Manabu Wadamoto, Minoru Yamawaki
  • PROCESS TO MAKE GLP1 RA AND INTERMEDIATES THEREFOR
    Publication number: 20250042899
    Abstract: The present invention relates to the synthesis of 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo [4,3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one, or a salt thereof, and related synthetic intermediate compounds.
    Type: Application
    Filed: September 3, 2024
    Publication date: February 6, 2025
    Inventors: Ayman D. ALLIAN, Kenneth Derek BERGLUND, Kevin Paul COLE, Ashlee Jeanette DAVIS, Molly HESS, Adriana JEMISON, Mark Steven KERR, Audrey Grace MACK, Xavier A. ORTIZ-MEDINA, David Michael REMICK, Derek Robert STARKEY, Radhe Krishan VAID, Qiang YANG